Equitable Holdings, Inc. Bluebird Bio, Inc. Transaction History
Equitable Holdings, Inc.
- $9.9 Billion
- Q3 2024
A detailed history of Equitable Holdings, Inc. transactions in Bluebird Bio, Inc. stock. As of the latest transaction made, Equitable Holdings, Inc. holds 25,050 shares of BLUE stock, worth $198,145. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25,050
Previous 15,050
66.45%
Holding current value
$198,145
Previous $14,000
7.14%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding BLUE
# of Institutions
141Shares Held
63.2MCall Options Held
264KPut Options Held
428K-
Black Rock Inc. New York, NY15.4MShares$122 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.5MShares$82.8 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA4.68MShares$37 Million0.0% of portfolio
-
Pictet Asset Management Sa Geneva 73, V84.67MShares$36.9 Million0.02% of portfolio
-
State Street Corp Boston, MA3.84MShares$30.4 Million0.0% of portfolio
About bluebird bio, Inc.
- Ticker BLUE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,121,800
- Market Cap $610M
- Description
- bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...